Transforming the R&D Model to Sustain Growth

To sustain rapid revenue growth, medical device manufacturers are increasingly turning to significant corporate cost saving programmes, often requiring across-the-board cuts between 15 and 30%.

Companies are under enormous pressure to introduce products to market faster while also meeting the escalating demands of regulators and payors for post-market research, requiring investment in infrastructure and expertise to maximise reimbursement and keep products on the market.

How can manufacturers effectively reconcile these seemingly contradictory challenges?

Read the white paper, Transforming Medical Device Development: Achieving Challenging Mandates for Cost Savings and Pipeline Productivity, to unlock three key strategies for maximising value from your strategic partnerships.

1. Discover why an innovation agenda holds the key to smarter execution

  • Find out how the right strategic partner can help you accomplish an innovation agenda that boosts productivity in six critical areas of clinical development.

2. Leverage targeted outsourcing for maximum benefit

  • Find an approach that suits your needs by exploring the features of five commonly used frameworks and essential best practises for outsourcing.

3. Evolve your partnership model

  • Learn how to implement an advanced partnership framework that enables productive collaboration and optimal protocol design.